AET BioTech is ready and prepared to assist biopharmaceutical companies to obtain marketing authorisation and to market their biosimilar products in Europe.

AET BioTech's experts are available to provide assistance throughout the entire biosimilar development program starting from cell line selection, development of active substance and finished product, pre-clinical and clinical testing up to interaction with the regulatory agencies, handling of the patent landscape and identification of marketing partners.